Mohamad Mehdi Feizabadi
Overview
Explore the profile of Mohamad Mehdi Feizabadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohsenipour Z, Arazi P, Skurnik M, Jahanbin B, Abtahi H, Edalatifard M, et al.
BMC Microbiol
. 2024 Dec;
24(1):516.
PMID: 39627702
Background: Predatory bacteria are Gram-negative microorganisms that grow within and lyse their bacterial prey. As bacterial predators have potential applications in medicine and biotechnology, the aim of this study was...
2.
Zafari M, Feizabadi M, Jafari S, Abdollahi A, Sabokbar A
Acta Microbiol Immunol Hung
. 2017 Sep;
64(4):385-394.
PMID: 28870091
Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii (CRAB) has created a public health concern all around the world. In this study, 100 isolates of CRAB from hospitalized patients during 2015-2016...
3.
Hashemi-Shahraki A, Heidarieh P, Bostanabad S, Hashemzadeh M, Feizabadi M, Schraufnagel D, et al.
Sci Rep
. 2015 Dec;
5:17862.
PMID: 26638771
The aim of this multicenter study was to determine the genetic diversity and antibiotic susceptibility of clinically isolated Nocardia species. One hundred twenty-seven patients with nocardiosis were randomly selected from...
4.
Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi M, Bostanabad S, Ghalami Nobar M, et al.
Microb Drug Resist
. 2015 Oct;
22(2):172-8.
PMID: 26468990
Many species of nontuberculous mycobacteria (NTM) have long been identified as important causes of human disease, the incidence of which is rising. Several reports have suggested increasing trend of both...
5.
Hashemi Shahraki A, Cavusoglu C, Borroni E, Heidarieh P, KOksalan O, Cabibbe A, et al.
Int J Syst Evol Microbiol
. 2014 Nov;
65(Pt 2):510-515.
PMID: 25389151
Six strains of a rapidly growing scotochromogenic mycobacterium were isolated from pulmonary specimens of independent patients. Biochemical and cultural tests were not suitable for their identification. The mycolic acid pattern...
6.
Shojaei H, Heidarieh P, Hashemi A, Feizabadi M, Naser A
Jpn J Infect Dis
. 2011 Jul;
64(4):265-71.
PMID: 21788699
In developing countries where tuberculosis is still a health challenge, the prevalence of nontuberculous mycobacterial diseases is expected to rise as medical conditions that compromise the immune system become more...
7.
Shojaei H, Hashemi A, Heidarieh P, Feizabadi M, Ataei B, Naser A
Jpn J Infect Dis
. 2011 May;
64(3):234-6.
PMID: 21617309
We herein present the third set of documented clinical Mycobacterium setense cases. Three clinically unrelated isolates were identified and characterized using various key conventional and molecular diagnostic tests. Phenotypic and...
8.
Heidarieh P, Shojaei H, Hashemi A, Feizabadi M, Daei-Naser A, Ataei B
JRSM Short Rep
. 2011 May;
2(4):26.
PMID: 21541074
No abstract available.
9.
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals
Taherikalani M, Morovat T, Fatolahzadeh B, Bahram F, Emaneini M, Mohammad E, et al.
New Microbiol
. 2009 Oct;
32(3):265-71.
PMID: 19845108
The MICs of imipenem, meropenem, piperacillin-tazobactam, cefotaxime, polymixin B and tigecycline against 80 isolates of Acintobacter baumanii from 6 hospitals were determined. A multiplex-PCR was used to detect the genes...